Skip to content
healthcare.dev

HYLAFEM BORICUM ACIDUM 3X

NDC 52747-255, Boricum Acidum, suppository, from U.S. PHARMACEUTICAL CORPORATION.

Product NDC
52747-255
Status
Listed
Labeler
U.S. PHARMACEUTICAL CORPORATION
Dosage form
SUPPOSITORY
Route
VAGINAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/52747-255 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BORIC ACID3 [hp_X]/1
Package NDCNDC-11Package
52747-255-03527470255031 CAPSULE in 1 CARTON (52747-255-03) / 3 SUPPOSITORY in 1 CAPSULE

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 52747-255 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/52747-255 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 52747-255. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.